About 12. 9 million people received at least one dose of the Pfizer or Moderna COVID-19 vaccines between Dec. 14 and Jan. 14, the first month of the U.S. COVID-19 vaccination program, the Centers for Disease Control and Prevention reported.
Novel Coronavirus (COVID-19) News
Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
Ten Republican senators released highlights from their $618 billion COVID-19 relief proposal, outlined Sunday in a letter to President Biden. The proposal includes $35 billion for the Provider Relief Fund, with 20% set aside for rural hospitals; $20 billion for vaccine efforts; and $50 billion for testing, among other provisions.
The Department of Health and Human Services amended its declaration under the Public Readiness and Emergency Preparedness Act to permit physicians, registered nurses and practical nurses whose license or certification has expired in the past five years to prescribe, dispense and/or administer COVID-19 vaccines in any state or U.S. territory.
Johnson & Johnson provided a concrete look at its COVID-19 vaccine candidate, revealing that its efficacy is expected to be sufficient to pursue an emergency use authorization from the Food and Drug Administration.
Our country is ready, eager and hopeful this year for at least a partial return to the pre-COVID-19 world. Everyone has a role to play in getting there.
South Carolina has reported the first documented U.S. cases of the SARS-CoV-2 variant first detected in South Africa, the Centers for Disease Control and Prevention announced.
In the midst of the tragedy that is the COVID-19 pandemic, one silver lining is how it has brought us together as an organization to help us innovate and realize our vision to make Indiana one of the healthiest states in the nation.
The Department of Health and Human Services today will amend the Public Readiness and Emergency Preparedness Act to permit doctors and nurses who have recently retired or become inactive to administer COVID-19 vaccines and anyone currently licensed to vaccinate in their state to administer shots across state lines, White House COVID-19 Response Coordinator Jeff Zients announced at the first regular briefing by the White House COVID-19 Response Team.
President Biden announced the federal government will purchase an additional 200 million doses of the two COVID-19 vaccines authorized by the Food and Drug Administration for emergency use.
The National Institutes of Health has launched an online data portal to collect clinical information on neurological symptoms, complications and outcomes related to COVID-19.
Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.
This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and supporting the physical and mental health of all staff.
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
“We have much to do, much to repair, much to restore, much to heal, much to build … and much to gain.”
AHA released its latest issue of the COVID-19 Snapshot, which underscores the dire needs of hospitals and health systems during the deepening public health emergency.
When hundreds of leaders gather virtually February 17–18 for the AHA Rural Health Care Leadership Conference, there will be opportunities for you to make, build and renew connections that help innovate and transform health care, through a pioneering approach toward conferencing.
The Food and Drug Administration updated its guidance and webpage on COVID-19 convalescent plasma.
The American Medical Association announced Current Procedural Terminology codes for reporting the single-dose Janssen (Johnson & Johnson) COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency use.